3

OWNERSHIP DOCUMENT

Company: Inhibrx Biosciences, Inc.
Filed: May 24, 2024
Period of Report: May 24, 2024
Accession Number: 0000950142-24-001421

View Document ↗ View on SEC.gov ↗